DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
VSCVX
Price
$38.03
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Net Assets
1.14B
Interact to see
Advertisement

DFSVX vs VSCVX

DFSVX vs VSCVX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. VSCVX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and VSCVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. VSCVX (1.14B). DFSVX pays higher dividends than VSCVX: DFSVX (1.50) vs VSCVX (0.54). DFSVX was incepted earlier than VSCVX: DFSVX (33 years) vs VSCVX (22 years). VSCVX (1.43) is less costly to investors than DFSVX (0.31). VSCVX is a more actively managed with annual turnover of: 44.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than VSCVX: DFSVX (0) vs VSCVX (2500). VSCVX annual gain was more profitable for investors over the last year : 38.10 vs. DFSVX (34.39). DFSVX return over 5 years is better than : 50.66 vs. VSCVX (-7.80).
DFSVXVSCVXDFSVX / VSCVX
Total Expense Ratio0.311.4322%
Annual Report Gross Expense Ratio0.311.4322%
Fund Existence33 years22 years-
Gain YTD21.33624.81186%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B1.14B1,706%
Annual Yield % from dividends1.500.54279%
Returns for 1 year34.3938.1090%
Returns for 3 years50.3711.28446%
Returns for 5 years50.66-7.80-650%
Returns for 10 years107.7124.99431%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I